By Steven Reinberg
HealthDay Reporter
TUESDAY, Feb. 7 (HealthDay News) — A drug used to prevent breast cancer in women at high risk for the disease appears to cause bone loss in some postmenopausal women, a new study finds.
The drug, Aromasin (exemestane), has been shown to reduce the odds of breast cancer by 65 percent, but it also worsens bone density by about three times in older women who are taking it, Canadian researchers report.
By Serena Gordon
HealthDay Reporter
TUESDAY, Feb. 7 (HealthDay News) — The risk of dying from a hormone receptor-positive breast cancer increases with age, according to new research. And one reason might be that older women with breast cancer are undertreated compared to their younger peers.
For women between the ages of 65 and 74, the risk of dying from breast cancer was 25 percent higher than for women under 65. For those 75 and older, the risk of death was 63 percent higher than for women under 65, according to the new study.
FRIDAY, Feb. 3 (HealthDay News) — Soy supplements do not protect women against breast cancer, a new study suggests.
The findings are consistent with the results of previous studies that examined the cancer prevention benefits of the dietary supplements, said lead researcher Dr. Seema Khan, a professor of surgery at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University.
Read More
WEDNESDAY, Feb. 1 (HealthDay News) — Exercise can improve the health, energy and well-being of cancer patients after they’ve completed their main cancer treatment, a new review finds.
University of Hong Kong researchers analyzed the results of 34 clinical trials that examined the effects of physical activity among adult patients with breast, prostate, gynecologic, colorectal, gastric or lung cancer.
By Serena Gordon
HealthDay Reporter
TUESDAY, Jan. 31 (HealthDay News) — Almost one-fourth of women who opt for breast-conserving surgery instead of mastectomy as an initial treatment for breast cancer need a second surgery to ensure all of the cancer cells are removed, a new study says.
New research has found that nearly 23 percent of women undergo a second procedure (medically known as re-excision), even though surgeons try to remove a clear “margin” — a thin rim of normal tissue — around the
tumor to catch any stray cancer cells.
By Kathleen Doheny
HealthDay Reporter
SUNDAY, Jan. 22 (HealthDay News) — Researchers have identified three new genomic regions they believe are linked with breast cancer that may help explain why some women develop the disease.
All three newly identified areas “contain interesting genes that open up new avenues for biological and clinical research,” said researcher Douglas Easton, a professor of genetic epidemiology at the University of Cambridge in England.
By Madonna Behen
HealthDay Reporter
FRIDAY, Jan. 20 (HealthDay News) — In too many cases, doctors aren’t doing a good job of informing American women with early stage breast cancer about the disease or their options in terms of surgery, a new study suggests.
In the study, researchers at the University of North Carolina surveyed breast cancer survivors on their knowledge of the disease. Respondents typically answered only about half of the questions correctly, and less than half said their surgeons had even asked them about their personal preference for surgery — a full mastectomy vs. breast-conserving lumpectomy — prior to treatment.
FRIDAY, Jan. 20 (HealthDay News) — Younger women with breast cancer may experience a decrease in their health-related quality of life because of increased mental distress, weight gain and other factors, a new study finds.
Decreased physical activity, infertility and early-onset menopause were among the other problems these women faced, according to the report published Jan. 20 in the Journal of the National Cancer Institute.
By Kathleen Doheny
HealthDay Reporter
TUESDAY, Jan. 17 (HealthDay News) — Combining two drugs that target an aggressive type of breast cancer known as HER2-positive appears to work better than using either drug alone, researchers report.
The dual-drug approach greatly boosted the chances of eliminating microscopic signs of early cancer by the time a woman was due to have surgery, said researcher Dr. Jose Baselga, chief of hematology/oncology at Massachusetts General Hospital Cancer Center and a professor of medicine at Harvard Medical School.
By Kathleen Doheny
HealthDay Reporter
THURSDAY, Jan. 12 (HealthDay News) — For several years, researchers have studied a possible link between substances called parabens — widely used as a germ-fighting preservative in cosmetics such as deodorant/antiperspirants — and breast cancer.
Investigators have learned that parabens, also found in some drugs and food products, can mimic weakly the action of the female hormone estrogen — an established risk factor for breast cancer. And the fact that a disproportionate number of breast tumors occur nearer the underarm also had scientists wondering.
| Text Size: |  |
|
